Kras regulatory elements and exon 4A determine mutation specificity in lung cancer

Minh D. To, Christine E. Wong, Anthony Karnezis, Reyno Del Rosario, Roberto Di Lauro, Allan Balmain

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model, we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development, it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele. Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications; therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.

Original languageEnglish (US)
Pages (from-to)1240-1244
Number of pages5
JournalNature Genetics
Volume40
Issue number10
DOIs
StatePublished - Oct 1 2008
Externally publishedYes

Fingerprint

Exons
Lung Neoplasms
Lung
Mutation
Protein Isoforms
Neoplasms
Skin
ras Genes
Post Translational Protein Processing
Human Activities
Carcinogenesis
Epithelium
Epithelial Cells
Alleles
Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Genetics

Cite this

To, M. D., Wong, C. E., Karnezis, A., Del Rosario, R., Di Lauro, R., & Balmain, A. (2008). Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. Nature Genetics, 40(10), 1240-1244. https://doi.org/10.1038/ng.211

Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. / To, Minh D.; Wong, Christine E.; Karnezis, Anthony; Del Rosario, Reyno; Di Lauro, Roberto; Balmain, Allan.

In: Nature Genetics, Vol. 40, No. 10, 01.10.2008, p. 1240-1244.

Research output: Contribution to journalArticle

To, MD, Wong, CE, Karnezis, A, Del Rosario, R, Di Lauro, R & Balmain, A 2008, 'Kras regulatory elements and exon 4A determine mutation specificity in lung cancer', Nature Genetics, vol. 40, no. 10, pp. 1240-1244. https://doi.org/10.1038/ng.211
To, Minh D. ; Wong, Christine E. ; Karnezis, Anthony ; Del Rosario, Reyno ; Di Lauro, Roberto ; Balmain, Allan. / Kras regulatory elements and exon 4A determine mutation specificity in lung cancer. In: Nature Genetics. 2008 ; Vol. 40, No. 10. pp. 1240-1244.
@article{161292da46e049b4a29af5aa5f1b6f67,
title = "Kras regulatory elements and exon 4A determine mutation specificity in lung cancer",
abstract = "Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model, we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development, it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele. Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications; therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.",
author = "To, {Minh D.} and Wong, {Christine E.} and Anthony Karnezis and {Del Rosario}, Reyno and {Di Lauro}, Roberto and Allan Balmain",
year = "2008",
month = "10",
day = "1",
doi = "10.1038/ng.211",
language = "English (US)",
volume = "40",
pages = "1240--1244",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Kras regulatory elements and exon 4A determine mutation specificity in lung cancer

AU - To, Minh D.

AU - Wong, Christine E.

AU - Karnezis, Anthony

AU - Del Rosario, Reyno

AU - Di Lauro, Roberto

AU - Balmain, Allan

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model, we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development, it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele. Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications; therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.

AB - Kras is the most frequently mutated ras family member in lung carcinomas, whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model, we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development, it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele. Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications; therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.

UR - http://www.scopus.com/inward/record.url?scp=52949118488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949118488&partnerID=8YFLogxK

U2 - 10.1038/ng.211

DO - 10.1038/ng.211

M3 - Article

C2 - 18758463

AN - SCOPUS:52949118488

VL - 40

SP - 1240

EP - 1244

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 10

ER -